ArticleAngewandte Chemie (International ed. in English)2026
Machine-Learning-Enabled Rapid Evolution of Photoenzymes for the Asymmetric Synthesis of gem-Difluorophosphonates.
Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
gem-Difluorophosphonates are pivotal structural motifs in pharmaceuticals and bioactive molecules. While photoenzymatic catalysis provides a powerful platform to overcome the challenges of enantioselective synthesis, engineering enzymes for non-natural transformations remains an arduous, labor-intensive process. Although predictive methods utilizing protein language models (PLMs) offer fitness landscape guidance, they often struggle to generalize across diverse protein families or accurately map sequence to catalytic activity. Here, we report a small-sample, accelerated evolution strategy that integrates focused rational iterative site-specific mutagenesis (FRISM) with the EVOLVEpro model. This synergistic approach identifies high-activity and enantiospecific variants through structure-based hotspot identification and active learning, requiring minimal experimental throughput. By screening only 40 variants over three evolutionary rounds, we identified four beneficial mutations whose combinations enable the synthesis of diverse fluorinated products with up to > 99% yield and 98:2 enantiomeric ratio (e.r.)-a 65% reduction in workload compared to exhaustive screening. Mechanistic investigations suggest an electron donor-acceptor (EDA)-complex-free radical addition pathway, terminated by the flavin semiquinone (FMN
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.